Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.
Thyroid cancer is the most common endocrine related cancer with increasing incidences during the past five years. Current treatments for thyroid cancer, such as surgery or radioactive iodine therapy, often require patients to be on lifelong thyroid hormone replacement therapy and given the significa...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3022654?pdf=render |
| _version_ | 1819181936774479872 |
|---|---|
| author | Shilpi Rajoria Robert Suriano Andrea George Arulkumaran Shanmugam Stimson P Schantz Jan Geliebter Raj K Tiwari |
| author_facet | Shilpi Rajoria Robert Suriano Andrea George Arulkumaran Shanmugam Stimson P Schantz Jan Geliebter Raj K Tiwari |
| author_sort | Shilpi Rajoria |
| collection | DOAJ |
| description | Thyroid cancer is the most common endocrine related cancer with increasing incidences during the past five years. Current treatments for thyroid cancer, such as surgery or radioactive iodine therapy, often require patients to be on lifelong thyroid hormone replacement therapy and given the significant recurrence rates of thyroid cancer, new preventive modalities are needed. The present study investigates the property of a natural dietary compound found in cruciferous vegetables, 3,3'-diindolylmethane (DIM), to target the metastatic phenotype of thyroid cancer cells through a functional estrogen receptor.Thyroid cancer cell lines were treated with estrogen and/or DIM and subjected to in vitro adhesion, migration and invasion assays to investigate the anti-metastatic and anti-estrogenic effects of DIM. We observed that DIM inhibits estrogen mediated increase in thyroid cell migration, adhesion and invasion, which is also supported by ER-α downregulation (siRNA) studies. Western blot and zymography analyses provided direct evidence for this DIM mediated inhibition of E(2) enhanced metastasis associated events by virtue of targeting essential proteolytic enzymes, namely MMP-2 and MMP-9.Our data reports for the first time that DIM displays anti-estrogenic like activity by inhibiting estradiol enhanced thyroid cancer cell proliferation and in vitro metastasis associated events, namely adhesion, migration and invasion. Most significantly, MMP-2 and MMP-9, which are known to promote and enhance metastasis, were determined to be targets of DIM. This anti-estrogen like property of DIM may lead to the development of a novel preventive and/or therapeutic dietary supplement for thyroid cancer patients by targeting progression of the disease. |
| first_indexed | 2024-12-22T22:38:09Z |
| format | Article |
| id | doaj.art-1e75dad241ab4df2aefdc2cb1de7d011 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T22:38:09Z |
| publishDate | 2011-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-1e75dad241ab4df2aefdc2cb1de7d0112022-12-21T18:10:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0161e1587910.1371/journal.pone.0015879Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.Shilpi RajoriaRobert SurianoAndrea GeorgeArulkumaran ShanmugamStimson P SchantzJan GeliebterRaj K TiwariThyroid cancer is the most common endocrine related cancer with increasing incidences during the past five years. Current treatments for thyroid cancer, such as surgery or radioactive iodine therapy, often require patients to be on lifelong thyroid hormone replacement therapy and given the significant recurrence rates of thyroid cancer, new preventive modalities are needed. The present study investigates the property of a natural dietary compound found in cruciferous vegetables, 3,3'-diindolylmethane (DIM), to target the metastatic phenotype of thyroid cancer cells through a functional estrogen receptor.Thyroid cancer cell lines were treated with estrogen and/or DIM and subjected to in vitro adhesion, migration and invasion assays to investigate the anti-metastatic and anti-estrogenic effects of DIM. We observed that DIM inhibits estrogen mediated increase in thyroid cell migration, adhesion and invasion, which is also supported by ER-α downregulation (siRNA) studies. Western blot and zymography analyses provided direct evidence for this DIM mediated inhibition of E(2) enhanced metastasis associated events by virtue of targeting essential proteolytic enzymes, namely MMP-2 and MMP-9.Our data reports for the first time that DIM displays anti-estrogenic like activity by inhibiting estradiol enhanced thyroid cancer cell proliferation and in vitro metastasis associated events, namely adhesion, migration and invasion. Most significantly, MMP-2 and MMP-9, which are known to promote and enhance metastasis, were determined to be targets of DIM. This anti-estrogen like property of DIM may lead to the development of a novel preventive and/or therapeutic dietary supplement for thyroid cancer patients by targeting progression of the disease.http://europepmc.org/articles/PMC3022654?pdf=render |
| spellingShingle | Shilpi Rajoria Robert Suriano Andrea George Arulkumaran Shanmugam Stimson P Schantz Jan Geliebter Raj K Tiwari Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. PLoS ONE |
| title | Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. |
| title_full | Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. |
| title_fullStr | Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. |
| title_full_unstemmed | Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. |
| title_short | Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer. |
| title_sort | estrogen induced metastatic modulators mmp 2 and mmp 9 are targets of 3 3 diindolylmethane in thyroid cancer |
| url | http://europepmc.org/articles/PMC3022654?pdf=render |
| work_keys_str_mv | AT shilpirajoria estrogeninducedmetastaticmodulatorsmmp2andmmp9aretargetsof33diindolylmethaneinthyroidcancer AT robertsuriano estrogeninducedmetastaticmodulatorsmmp2andmmp9aretargetsof33diindolylmethaneinthyroidcancer AT andreageorge estrogeninducedmetastaticmodulatorsmmp2andmmp9aretargetsof33diindolylmethaneinthyroidcancer AT arulkumaranshanmugam estrogeninducedmetastaticmodulatorsmmp2andmmp9aretargetsof33diindolylmethaneinthyroidcancer AT stimsonpschantz estrogeninducedmetastaticmodulatorsmmp2andmmp9aretargetsof33diindolylmethaneinthyroidcancer AT jangeliebter estrogeninducedmetastaticmodulatorsmmp2andmmp9aretargetsof33diindolylmethaneinthyroidcancer AT rajktiwari estrogeninducedmetastaticmodulatorsmmp2andmmp9aretargetsof33diindolylmethaneinthyroidcancer |